Showing 8,041 - 8,060 results of 100,406 for search '(( e nn decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.41s Refine Results
  1. 8041

    THS exposure in conjunction with antioxidant treatment for 2.5 and 5 months alleviates metabolic syndrome in a dose-dependent manner. by Neema Adhami (516427)

    Published 2016
    “…<p><b>(A)</b> THS-exposed mice treated with antioxidants for 5 months have reduced visceral fat accumulation compared to THS exposed mice. …”
  2. 8042
  3. 8043
  4. 8044
  5. 8045
  6. 8046
  7. 8047

    Table 2_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”
  8. 8048

    Table 1_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”
  9. 8049

    Table 3_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”
  10. 8050

    Validation of RNA-sequencing by Q-PCR and effects of 5Aza-dC on a subset of DM and DE genes in CESC and OESC. by Iveta Yotova (451965)

    Published 2017
    “…<b>A)</b> The relative expression of <i>SLC22A23</i> under treatment with 5aza-dC increases in CESC as well as in OESC. …”
  11. 8051
  12. 8052
  13. 8053

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  14. 8054
  15. 8055
  16. 8056
  17. 8057
  18. 8058
  19. 8059
  20. 8060